NorthWest Biotherapeutics Inc (NWBO)

[highwayman4life]

Try and stay clam Ex. I can see things have got you a bit worked up but truth be told, you will have answers soon enough. Results will be unblinded when they are ready...not in 10 yrs as you surmise.

Then and only then will you and the rest of us know if the Grapefruit juice is effective.

Given your efforts here as a DooGooder, you should be warning investors of companies such as CLDX and the likes of Dr. Wheeler. You may not like LP and obviously take issue with the 2007 PR of approval in Switzerland, corp governance issues, her business structure etc.. but given recent comments from Dr. Cobbs and Dr. Ashkan, it looks like the results which will in fact be released in the DCVax L trial look promising.

I've attached for you the reason behind the multiple antigen approach of DCVax b/c it appears you might be a little confused in your understanding.

Here is Dr. Ashkan speaking about DCVax:

Given his Bio and Associations, he may have...well...better insight into the field than certain posters here:

Professional memberships:
British Medical Association
Society of British Neurological Surgeons
British Neuro-Oncology Society
European Association of Neurosurgical Societies
Movement Disorder Society
Medical Defence Union

Biography
Prof Ashkan is a Professor of Neurosurgery with a specialist interest in functional and image guided neurosurgery, neuro-oncology and spine disease.

He trained at the University of Wales, College of Medicine and then completed an intensive general neurosurgical training programme on the South Thames Specialist Registrar rotation, working in several leading units such as King’s College, Atkinson Morley and The National Hospitals.

Prior to his Consultant appointment at King’s College Hospital he was previously a Senior Lecturer in Functional Neurosurgery and Honorary Consultant Neurosurgeon at the Institute of Neurology and the National Hospital for Neurology and Neurosurgery.

Prof Ashkan is the clinical lead for neuro-oncology at King's College Hospital. He has an active research interest in brain tumours and movement disorders and heads the Neuroscience Clinical Trial Unit. He has over 270 publications; serves on a number of international committees and is a reviewer for several high impact medical journals.

It certainly does get confusing at times when you have other "very" relevant researchers in the field like Mr. Feurerstein and Dr. Tony Schwartz who attempt to factually (they actually never present facts th ough) discredit DCVax.

For myself and probably a few others here, I'm going to listen to the likes of Dr. Liau, Dr. Ashkan, Dr. Cobbs, Dr. Cloughesy, Dr. Bosch, Dr. Maida etc...mostly b/c they are out there in the field with first hand experience and not posting here on a message board where other pseudo experts are.

What a shame if all your efforts to discredit a company, the Doctors involved and a possible improvement in the current SOC for GBM were all for naught.

I feel the upcoming Publication that at least some of us are anticipating will answers many questions and go on to prove all the message board pseudo experts to be phony, vile posers.

GLTA...well, mostly all